The taxes are part of the president's push to rein in the pharmaceutical industry and bring manufacturing to the U.S.
The volume of evidence behind a therapy has become inversely correlated with public trust in it,” writes Vikas Patel.
The final regulation, released Thursday by President Trump’s Centers for Medicare and Medicaid Services, is significantly ...
A Supreme Court ruling this week on gender and sexuality “conversion therapy” could narrow the authority of state medical ...
Lenacapavir could put the end of the HIV epidemic in reach — if the people who need it can access it. Here’s one way to make ...
The CDC has “temporarily paused” diagnostic testing for rabies and pox viruses, according to a recent update to the agency ...
The Trump administration is negotiating new drug-pricing deals, now with smaller companies, according to three people with ...
On top of being a day for brands to post “pranks” on social media, April 1 was also the deadline to apply for the CMMI ACCESS ...
Cuts to health care spending might play a role in a complicated Congressional maneuver to fund immigration enforcement.
The FDA yesterday approved Eli Lilly’s weight loss pill, orforglipron. The agency is also facing renewed scrutiny over ...
Biotech’s most-watched stock index, the XBI, was heading for a first-quarter loss until Tuesday, when Eli Lilly said it was ...
The EPA names microplastics as a potential drinking water contaminant, a move that is seen as an appeal to Kennedy's MAHA movement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results